Surface photochemical studies of nano-hybrids of A3B porphyrins and Fe3O4 silica-coated nanoparticles

https://doi.org/10.1016/j.jphotochem.2019.112152Get rights and content

Highlights

Abstract

This study reports a surface photochemistry behaviour of two tetrapyrrolic structures: 5,10,15,20-tetra-(4-carboxymethylphenyl) porphyrin (P1.1) and 5-(4-hydroxy-3-methoxyphenyl)-10,15,20-tris-(4-carboxymethylphenyl) porphyrin (P1.2), covalently bound to silica-coated magnetite nanoparticles (Fe3O4@SiO2) imbibed into a polyethylene glycol (PEG) matrix and in the form of a fine powder. The initial compounds and the nano-hybrids imbibed in the PEG matrix were characterized using Fourier transformed infrared spectroscopy (FT-IR), diffuse reflectance absorption spectroscopy for ground state molecules (GSDR), X-ray diffaction (XRD), transmission electron electron microscopy (TEM) as well as several luminescence emission spectroscopies. The combined use of these methodologies enabled us to obtain a surface photochemistry characterization of these new nano-hybrid materials.

For the powdered samples of P1.1 or P1.2 and Fe3O4@SiO2 imbibed into the powdered PEG a detailed absorption study and a correlation of fluorescence emission intensity with the magnetite concentration were performed. New covalent bonds porphyrin-Fe3O4@SiO2 were detected using FT-IR transmission spectra. A donor-acceptor interaction with change of the oxidation level of the porphyrins was also observed. Fluorescence emission quantum yields and lifetimes of the two porphyrins were determined for all samples and two populations of the porphyrin molecules exist, free porphyrin (unquenched) and porphyrin with Fe3O4@SiO2 NPs attached, the quenched porphyrin. In this way, the amount of the available excited porphyrin for singlet oxygen formation is reduced, therefore the presence of the Fe3O4@SiO2 NPs may not favor this specific PDT action by the Type II mechanism, but it prevents aggregation of the porphyrins, even when a PEG matrix is used, and Type I mechanisms remain active.

Introduction

Photodynamic therapy (PDT) is now a well-established methodology for cancer treatment and porphyrins or porphyrin-based photosensitizers (PSs) have been the most commonly used compounds up to now [[1], [2], [3], [4]]. Some new families of compounds are being tested for the production of reactive oxygen species (ROS), the most relevant phototoxic agents. Among them, squaraines and squaraine derivatives should be mentioned [[5], [6], [7], [8]].

PDT is a two stage procedure and, following an administration procedure, the photosensitizer should be exposed to the light of a suitable wavelength in the phototherapeutic range (650–850 nm, according to [4]). In this way the PSs are promoted to an excited state that may interact with ground state oxygen, enabling the formation of singlet oxygen. This species is considered to be the main cytotoxic agent in the photodynamic effect [9], causing the cell death of the malignant tissues.

In this study we are particularly interested in topic applications of the porphyrins, following previous studies of cytotoxic agents in films of chitosan (CS) or polyethylene glycol (PEG) [10,11]. In this paper, and following a recent work where the aggregation of two porphyrins in powdered samples of PEG was studied [12], we will pursue the study of two other porphyrins in solid powdered supports, but covalently linked to silica coated magnetite, also for topic applications. PEG is a biocompatible material allowing a topic use of the nano-hybrid material [10,11].

The aggregation of the porphyrin molecules plays a very significant role in their photochemical/photophysical behaviour, especially when adsorbed onto solid substrates, films or powders. Studies performed up to now indicate that fluorescence emission quantum yields and singlet oxygen quantum yields of aggregated porphyrins are lower than those obtained for the monomeric forms of the porphyrins [13,14]. In many cases the monomeric forms of porphyrins exhibit a high quantum yield of 1O2* generation (ΦΔ) and a relatively low cytotoxicity in the dark [2].

Recent studies of our group indicate that important improvements in the phototherapy efficiency can be obtained with the use of asymmetrical porphyrins, namely A3B forms, which are very promising photosensitizers for PDT [12,[15], [16], [17], [18]]. An effective photosensitizer, should take into account an optimal balance between the hydrophilic and hydrophobic substituents in the tetrapyrrolic structure, thus trying to achieve an optimum uptake in the tumour tissue [8]. Several studies of porphyrins were performed, aiming at the synthesis and photochemical/photocytotoxicity characterization of new compounds to be used in the photodynamic therapy of cancer (PDT) [12,[15], [16], [17], [18]].

Iron oxide magnetic nanoparticles have received considerable attention because of their prospects to be used in biological and medical applications. They exhibit unique magnetic, non-toxic, highly biocompatible properties, with potential application in drug delivery, biological separation and bio-catalysis [19].

In this study, two porphyrins recently synthetized and reported in reference [16], 5,10,15,20-mesotetrakis-(4-carboxymethylphenyl) porphyrin (P1.1), the fully symmetric substituted compound (A4 type), and 5-(4-hydroxy-3-methoxyphenyl)-10,15,20-tris-(4-carboxymethylphenyl) porphyrin (P1.2), a A3B type porphyrin (Scheme 1), were covalently bound to silica-coated magnetite nanoparticles (Fe3O4@SiO2) and imbibed into a polyethylene glycol (PEG) matrix, in the form of a fine powder.

Here we present a study of the two porphyrins P1.1 or P1.2@ Fe3O4@SiO2 nano-hybrids imbibed into the biocompatible material PEG, aiming a full surface photochemistry characterization of these new nano-hybrid materials.

Section snippets

Reagents and samples’ preparation

Commercially available chemicals and solvents were used as received from Sigma Aldrich. When available the solvents under use were of a spectroscopic grade. For the sample preparation of the powdered samples, dioxane (anhydrous, 99.8%) was used to solubilize both PEG (BioUltra 20,000) and the porphyrins. After the solvent evaporation the samples were ground with the use of a mortar and pestle, and then dried in a vacuum oven at room temperature. For the synthesis of Fe3O4 NPs, the reagents were

TEM images for Fe3O4, Fe3O4@SiO2 and P1.1 or P1.2@ Fe3O4@SiO2 NPs

Two kinds of nanoparticles were investigated initially: pure magnetite particles treated with oleic acid and magnetite coated with SiO2. The particle size distributions of the samples were obtained statistically by measuring the diameter of the nanoparticles using TEM images as shown in Fig. 1 and Fig. 2, Scheme 1 and Scheme 2. For the silica NPs the dimensions of the nanoparticles were evaluated by the use of SEM, and one figure is presented as supplementary material (Figure S1).

TEM images of

Conclusions

Two porphyrins, P1.1 or P1.2 were linked to silica coated magnetite nanoparticles, and imbibed into a PEG matrix. Powdered samples of these nano-hybrids were submitted to a detailed study aiming to obtain a surface photochemistry characterization of these new nano-hybrid materials. Ground state absorption spectra, a correlation of the absolute fluorescence emission quantum yields and lifetimes of the singlet excited state for the two porphyrins as a function of the coated magnetite

Acknowledgments

The research was supported by the M-ERA. NET project NANOTHER - ctr. no. 53/2016, ctr. no. 54/2016 from Romania, M-ERA-NET/0002/2015 and UID/NAN/50024/2013 from FCT, Portugal. The Authors acknowledge Helena Liberato for a final careful reading of the manuscript.

References (46)

  • R. Socoteanu et al.

    Biomedical Engineering - from Theory to Applications in Ed. Reza Fazel-rezai

    (2011)
  • A.E. O’Connor et al.

    Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy

    Photochem. Photobiol.

    (2009)
  • D. Van Straten et al.

    Oncologic photodynamic therapy: basic principles, current clinical status and future directions

    Cancers (Basel)

    (2017)
  • Á.F. Magalhães et al.

    Synthesis, photochemical and in vitro cytotoxic evaluation of benzoselenazole-based aminosquaraines

    Photochem. Photobiol. Sci.

    (2019)
  • F. Mandim et al.

    Synthesis, photochemical and in vitro cytotoxic evaluation of new iodinated aminosquaraines as potential sensitizers for photodynamic therapy

    Molecules

    (2019)
  • D.P. Ferreira et al.

    Photochemical properties of squarylium cyanines dyes

    Photochem. Photobiol. Sci.

    (2013)
  • M. Niedre et al.

    Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo

    Photochem. Photobiol.

    (2002)
  • D.P. Ferreira et al.

    Characterization of a Squaraine/Chitosan system for photodynamic therapy of Cancer

    J. Phys. Chem. B

    (2016)
  • L.F. Vieira Ferreira et al.

    Photochemical/Photocytotoxicity studies of new tetrapyrrolic structures as potential candidates for cancer theranostics

    Curr. Drug Discov. Technol.

    (2019)
  • L.M. Moreira et al.

    Photodynamic therapy: porphyrins and Phthalocyanines as photosensitizers

    Aust. J. Chem.

    (2008)
  • G. Zampini et al.

    Effects of gold colloids on the photosensitization. Efficiency of silica particles doped with protoporphyrin IX

    Chem. Photo. Chem.

    (2017)
  • R. Boscencu et al.

    Studies on the synthesis, photophysical and biological evaluation of some unsymmetrical meso-tetrasubstituted phenyl porphyrins

    Molecules

    (2017)
  • G. Manda et al.

    Emerging therapeutic targets in oncologic photodynamic therapy

    Curr. Pharm. Des.

    (2018)
  • Cited by (8)

    View all citing articles on Scopus
    View full text